Celldex Therapeutics (CLDX) Operating Leases (2019 - 2026)
Celldex Therapeutics' Operating Leases came in at $3.35 million for Q2 2026, up 123.9% from $1.5 million a year earlier and up 655.5% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Operating Leases was $784,000, down 66.8% from FY2024.
- Operating Leases carries a five-year compound annual growth rate of -18.3% (FY2020 to FY2025).
- Going back by year, Operating Leases was $2.36 million in FY2024 (+154.4%), $928,000 in FY2023 (-64.1%), $2.59 million in FY2022 (+99.7%) and $1.3 million in FY2021 (-39.8%).
- The Q2 2026 figure represents the highest quarterly Operating Leases in data going back to Q1 2019.
- Year-over-year, Operating Leases increased in five of the last eight quarters, with growth averaging 65.8%.
- The fastest year-over-year change in Operating Leases over five years came in Q1 2025 (growth of 310.4%), and the weakest in Q1 2024 (a decline of 78.2%).
- Business Quant data shows CLDX's Operating Leases at $443,000 (Q1 2026), $784,000 (Q4 2025) and $1.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.35 Mn |
| Mar 31, 2026 | 443,000.00 |
| Dec 31, 2025 | 784,000.00 |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 2.36 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 796,000.00 |
| Mar 31, 2024 | 470,000.00 |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 2.59 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 841,000.00 |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 1.71 Mn |
API Access
Celldex Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();